Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC-MS/MS method for the analysis of estradiol product formation.
Azoles are used as fungicides in agriculture or antifungal drugs in medicine. Their therapeutic activity is based on the inhibition of fungal lanosterol-14alpha-demethylase (CYP51). Azoles are also used for the treatment of estrogen-dependent diseases, e.g. in breast cancer therapy. Inhibition of CYP19 (aromatase) is the working principle for tumor therapy, but is an unwanted side effect of azoles used as fungicides or antifungal drugs. The inhibition of recombinant human CYP19 by 21 azoles in use for the three different purposes was investigated using the natural substrate testosterone. Estradiol product formation was measured by a newly developed and fully validated analytical method based on liquid chromatography-tandem mass spectrometry utilizing photospray ionization (APPI). Potency of enzyme inhibition was expressed in terms of IC50 concentrations. The two cytostatic drugs fadrozole and letrozole were the most potent inhibitors. However, azoles used as fungicides, e.g. prochloraz, or as antifungal drugs, e.g. bifonazole, were almost as potent inhibitors of aromatase as the drugs used in tumor therapy. Comparison of plasma concentrations that may be reached in antifungal therapy do not allow for large safety factors for bifonazole and miconazole. The IC50 values were compared to data obtained with other substrates, such as the pseudo-substrate dibenzylfluorescein (DBF). A high correlation was found, indicating that the fluorescence assay with DBF can well be used for potency ranking and screening of chemicals for aromatase inhibition. The data for antifungal drugs show that side effects on steroid hormone synthesis in humans due to inhibition of aromatase should be considered.
Trösken
Eva R
ER
Department of Toxicology, University of Würzburg, 9 Versbacher St., 97078 Würzburg, Germany.
Fischer
Kathrin
K
Völkel
Wolfgang
W
Lutz
Werner K
WK
D000935:Antifungal Agents / Q000494:pharmacology*; D047072:Aromatase Inhibitors / Q000494:pharmacology*; D001393:Azoles / Q000494:pharmacology*; D002784:Cholesterol / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D002853:Chromatography, Liquid; D004791:Enzyme Inhibitors; D004958:Estradiol / Q000378:metabolism*; D005456:Fluorescent Dyes; D005659:Fungicides, Industrial / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007202:Indicators and Reagents; D008861:Microsomes / Q000201:enzymology; D013057:Spectrum Analysis
D000935:Antifungal Agents; D047072:Aromatase Inhibitors; D001393:Azoles; D004791:Enzyme Inhibitors; D005456:Fluorescent Dyes; D005659:Fungicides, Industrial; D007202:Indicators and Reagents; D004958:Estradiol; D002784:Cholesterol